Search Tag: Radiopharmaceuticals

IMAGING Management

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals to top £800 Million by 2017

2013 30 May

The Asia-Pacific radiopharmaceutical market was valued at $500.8 million in 2012 and is poised to reach $824.9 million by 2017 at a Compound Annual Growth Rate (CAGR) of 10.5 percent, according to a report from Markets and Markets.The "Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market & Stable Isotopes [SPECT/PET Radioisotopes (Technetium, F-18)],... Read more

IMAGING Management

Global Nuclear Medicine/Radiopharmaceuticals Market To Reach $5bn

2013 15 May

Research and Markets has published  "Nuclear Medicine/Radiopharmaceuticals [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha radiation therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) Market - Global Trends & Forecast to 2017" The global radiopharmaceuticals market was valued at $3.8 billion... Read more

IMAGING Management

North American Nuclear Medicine/ Radiopharmaceuticals Market To Top $2 Billion by 2017

2013 03 May

The North American radiopharmaceuticals market was valued at $1.9 billion in 2012 and is poised to reach $2.7 billion by 2017 at a CAGR of 7.2 percent, according to a new report from Reportlinker.com, "North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy... Read more

IMAGING Management

Nuclear Medicine and Radiopharmaceuticals Market 2012-2017

2013 29 Apr

Markets and Markets has released a new report on the nuclear medicine and radiopharmaceuticals market.The Nuclear Medicine/ Radiopharmaceuticals Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) - Global Trends & Forecast To... Read more

IMAGING Management

New Imaging Agent Enables Better Cancer Detection and Staging

2013 24 Apr

Researchers at the University of California, San Diego School of Medicine have shown that a new imaging dye is an effective agent in detecting and mapping cancers that have reached the lymph nodes. The radioactive dye, called Technetium Tc-99m tilmanocept, successfully identified cancerous lymph nodes and did a better job of marking cancers than the... Read more

IMAGING Management

Navidea Lymphoseek® Gains FDA Approval

2013 16 Apr

Navidea Biopharmaceuticals, a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, has announced U.S. Food and Drug Administration (FDA) approval of Lymphoseek® (technetium Tc 99m tilmanocept) Injection, which is indicated for use in lymphatic mapping procedures to assist in the localisation of lymph nodes draining a primary... Read more

IMAGING Management

The European Nuclear Medicine / Radiopharmaceuticals Market

2013 08 Apr

Markets and Markets has announced the release of a report on the European nuclear medicine market over the forecast period 2012-2017.The European radiopharmaceutical market was valued at $1.1 billion in 2012 and is poised to reach $1.6 billion by 2017 at a CAGR of 6.8%.The radioisotopes market is categorised into diagnostic and therapeutic applications.... Read more


Endorsed Companies